These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 30674380

  • 1. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Reimann M, Schaub D, Kalsdorf B, Runge C, Carballo PS, Terhalle E, Salzer HJF, Lange C, Heyckendorf J.
    Int J Tuberc Lung Dis; 2019 Jan 01; 23(1):93-98. PubMed ID: 30674380
    [Abstract] [Full Text] [Related]

  • 2. Treatment responses in multidrug-resistant tuberculosis in Germany.
    Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C.
    Int J Tuberc Lung Dis; 2018 Apr 01; 22(4):399-406. PubMed ID: 29562987
    [Abstract] [Full Text] [Related]

  • 3. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M, Caminero Luna J, Migliori GB, D'Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, Torres-Cruz A, Flores-Ergara H, Martínez-Mendoza D, García-Sancho C, Centis R, Salazar-Lezama MÁ, Pérez-Padilla R.
    Rev Port Pneumol (2006); 2017 Apr 01; 23(1):27-30. PubMed ID: 28043788
    [Abstract] [Full Text] [Related]

  • 4. Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis.
    Takasaka N, Seki Y, Fujisaki I, Uchiyama S, Matsubayashi S, Sato A, Yamanaka Y, Odashima K, Kazuyori T, Seki A, Takeda H, Ishikawa T, Kuwano K.
    BMC Pulm Med; 2020 Nov 07; 20(1):287. PubMed ID: 33160360
    [Abstract] [Full Text] [Related]

  • 5. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 6. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C, German TBNET Group.
    Emerg Infect Dis; 2008 Nov 15; 14(11):1700-6. PubMed ID: 18976552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.
    Int J Tuberc Lung Dis; 2012 Sep 15; 16(9):1228-33. PubMed ID: 22748131
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J.
    J Antimicrob Chemother; 2015 Feb 15; 70(2):456-62. PubMed ID: 25266071
    [Abstract] [Full Text] [Related]

  • 14. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Feb 15; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 15. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.
    Int J Tuberc Lung Dis; 2013 Mar 15; 17(3):348-53. PubMed ID: 23321297
    [Abstract] [Full Text] [Related]

  • 16. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 15; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 17. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.
    Clin Infect Dis; 2008 Aug 15; 47(4):450-7. PubMed ID: 18616396
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J.
    Int J Tuberc Lung Dis; 2018 Jan 01; 22(1):54-59. PubMed ID: 29297426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A, Parthasarathy G, Burma SP, Sugunan AP, Vijayachari P.
    Indian J Tuberc; 2015 Jan 01; 62(1):23-8. PubMed ID: 25857562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.